Ronald Vogels,Maria Grazia Pau,Lennart Holterman,Stefan Kostense,Menzo Jans Emco Havenga,Mieke Caroline Sprangers
申请号：
US13199285
公开号：
US08227243B2
申请日:
2011.08.23
申请国别(地区):
US
年份:
2012
代理人:
摘要：
Described are new uses of recombinant adenoviral vectors in vaccination regimens, such as prime/boost set-ups and subsequent vaccinations and applications for gene therapy. Moreover, also described are new assays to determine the best regimen for applying the most suitable recombinant viral vector in a vaccination or gene therapy setting.
